1
HARRIMAN Geraldine C, MASSE Craig E, HARWOOD James, BHAT Sathesh, GREENWOOD Jeremy Robert: [fr] INHIBITEURS DE LACC ET UTILISATIONS ASSOCIÉES, [en] ACC INHIBITORS AND USES THEREOF. NIMBUS APOLLO, ROBIDOUX Andrea LC, May 16, 2013: WO/2013/071169 (6 worldwide citation)

[en] The present invention provides compounds, specifically thienopyrimidine derivatives, useful as inhibitors of Acetyl CoA Carboxylase (ACC), pharmaceutical compositions thereof, and methods of using the same for treating ACC-mediated disorders such as obesity, dyslipidemia, hyperiipidemia, fungal ...


2
Geraldine C Harriman, Craig E Masse, James Harwood, Sathesh Bhat, Jeremy Robert Greenwood: ACC inhibitors and uses thereof. Nimbus Apollo, Choate Hall & Stewart, Andrea L C Reid, Thomas H McLean, March 3, 2015: US08969557 (1 worldwide citation)

The present invention provides compounds useful as inhibitors of Acetyl CoA Carboxylase (ACC), compositions thereof, and methods of using the same.


3
ACC INHIBITORS AND USES THEREOF. Nimbus Apollo, May 16, 2013: US20130123231-A1

The present invention provides compounds useful as inhibitors of Acetyl CoA Carboxylase (ACC), compositions thereof, and methods of using the same.


4
GREENWOOD Jeremy Robert, HARRIMAN Geraldine C, BORG George, MASSE Craig E: [fr] INHIBITEURS DE LACC ET UTILISATIONS ASSOCIÉES, [en] ACC INHIBITORS AND USES THEREOF. NIMBUS APOLLO, MCLEAN Thomas H, November 13, 2014: WO/2014/182951

[en] The present invention provides for compounds of formula I as acetyl-CoA carboxylase (ACC) inhibitors. The ACC inhibitors are useful for the prevention or treatment of metabolic syndrome, including obesity, dyslipidemia and hyperlipidemia in humans. The inhibitor compounds are also capable of in ...